The corporate governance, strategic direction and performance of Lung Foundation Australia are the responsibility of our Board of Directors. Led by Professor Christine Jenkins, our Board delegates responsibility for day-to-day operations to our CEO who, together with our Executive Team, is accountable to the Board.
The Lung Foundation Australia Board consists of eight directors who volunteer their expertise and time to help improve lung health and reduce the impact of lung disease for all Australians.
Professor Christine Jenkins AM
Chair, Board Member since September 2012
Professor Christine Jenkins has a strong commitment to respiratory practice and clinical research, particularly in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD). She is the Clinical Professor at the University of Sydney, Department of Thoracic Medicine, Concord Hospital, and Head of the Respiratory Group at The George Institute for Global Health, Sydney, Australia. Professor Jenkins has played major roles in advocacy and leadership for lung health in Australia, has over 160 publications including three books, and has contributed to respiratory guidelines in Australia and internationally. She has made significant contributions to the community sector through senior leadership positions for government, health professional and not-for-profit organisations. She was awarded Member, Order of Australia in 2002 for Services to Respiratory Medicine, and was President of the Thoracic Society of Australia and New Zealand from 2007-2009.
Mr Andrew Churchill
Deputy Chair, Board Member since September 2012
Mr Andrew Churchill is an experienced executive and director with a strong business background in the professional services, telecommunications and information technology sectors. Mr Churchill has significant experience in strategy development and implementation paired with strong financial management skills. He has provided a range of business management, mentoring, coaching and advisory services through his management services firm Churchill Associates, and has previously held CEO and board positions in both private and public companies.
Professor Martin Phillips
Board Member since September 2012
Professor Martin Phillips is a Clinical Professor at the University of Western Australia and a Respiratory Physician at Sir Charles Gairdner Hospital in Perth where he is the Director of the Lung Cancer Service and Interventional Pulmonology Service. He has served on several committees in the Thoracic Society of Australia and New Zealand and co-chaired Special Interest Groups in lung cancer and interventional pulmonology. His research interests include asthma, Chronic Obstructive Pulmonary Disease (COPD), lung cancer and interventional pulmonology. Professor Phillips also delivers practical training courses each year on interventional pulmonology and medical thoracoscopy.
Professor Peter Frith
Board member since March 2013
Professor Peter Frith is an experienced respiratory physician who specialises in chronic disease management – specifically Chronic Obstructive Pulmonary Disease (COPD), pulmonary rehabilitation, self-treatment for people with chronic diseases, and mental health comorbidities related to lung disease. He is currently a Professor in Respiratory Medicine at Flinders University. Professor Frith is also the past Chair of the Lung Foundation’s COPD National Program and has served as convenor of the Thoracic Society of Australia and New Zealand’s COPD Special Interest Group. He has published over 150 peer-reviewed papers throughout his career, serves on the Board of GOLD (the Global COPD Initiative), and remains active in research today.
Dr David Michail
Board member since March 2013
Dr David Michail is a Consultant Respiratory and Sleep Physician working as a Senior Visiting Medical Officer at Westmead Hospital and with specialist services. He is the Clinical Lead of the Western Sydney Multidisciplinary Lung Cancer Group and is the Director of the Pulmonary Hypertension Service at Westmead Hospital, as well as a member of the Clinical Trials Program of the Ludwig Engel Centre for Respiratory Research. In addition to his roles in lung cancer and pulmonary hypertension, he has key interest in ambulatory models of care for sleep disorders and their management in primary care. Dr Michail also chairs Lung Foundation Australia’s national program on pulmonary arterial hypertension.
Ms Kathleen Cummings
Board member since April 2014
Kathleen has 30 years of experience in the banking and finance industry. She is highly experienced in strategic planning, financial and risk management, and specialises in distribution and talent management. As an integral member of the Retail Banking Leadership Team, Kathy built CommBank’s mortgage broker business from start-up to its current market dominance. She also played a key role in the evolution of the mortgage broking industry through her thought leadership and direct involvement with the predominant industry body, the Mortgage and Finance Association of Australia.
A/Professor Sarath Ranganathan
Board member since April 2014
A/Professor Sarath Ranganathan is an experienced and internationally recognised paediatric respiratory physician and medical researcher. He is currently the Director of Respiratory Medicine at the Royal Children’s Hospital in Melbourne and a leading authority on the role of infant pulmonary function testing in young children with cystic fibrosis. His areas of expertise include cystic fibrosis, paediatric asthma, allergy, paediatric bronchoscopy and tuberculosis, and lower respiratory tract infection. A/Professor Ranganathan has also published more than 150 peer-reviewed publications.
Mr Tony Hyams AM
Board member since November 2014
Mr Tony Hyams is highly experienced in banking, finance and investment. He was previously Head of Credit Suisse in Australia and is now an Independent Adviser to the Credit Suisse Group. He has held numerous Board positions including inaugural Chairman of The Commonwealth Superannuation Corporation, Chairman of the Military
Superannuation and Benefits Board, as well as Director of the Australian Government Employees Superannuation Trust. He has degrees in Law and Commerce, has been a participant at the World Economic Forum and is also a member of the Law Institute of Victoria. Tony is currently a Governor of WWF Australia and has been named a Member of the Order of Australia.
Dr Briony Scott
Board Member since July 2017
Dr Briony Scott is the Principal at Wenona School and, having been diagnosed with lung cancer in April 2015, now a passionate and respected lung cancer advocate. Briony is focused about raising awareness around the lack of research, funding, treatment and support available for people living with lung cancer and other lung diseases. She is well-respected amongst networks within the community as well as with clinicians, which she channels through her role on the Lung Foundation Australia board. Briony regularly engages in community forums, conferences, the media on education, leadership, parenting and has specialised in motivational theory, technology, and gender equity.
Clockwise from top left: Andrew Churchill, A/Prof Sarath Ranganathan, Tony Hyams AM, Prof Martin Phillips, Dr David Michail, Kathleen Cummings, Prof Christine Jenkins AM (Chair) and Prof Peter Frith.